To test this hypothesis, peripheral blood monocytes were isolated from 19 RA patients who were ACPA-positive and treatment-naive and were cultured with ACPA immune complexes in the absence (mock) or presence of abatacept. The gene discussed is PRTN3; the disease is rheumatoid arthritis.